Clinical Trials Directory

Trials / Unknown

UnknownNCT05772026

Plasma Proteomics in Patients With Postoperative Delirium

Serum Biomarkers for Postoperative Delirium Based on Plasma Proteomic Analysis of Elder Patients Undergoing Cardiac Surgery

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Xuzhou Central Hospital · Academic / Other
Sex
All
Age
65 Years – 85 Years
Healthy volunteers
Accepted

Summary

Patients undergoing cardiac surgery were recruited. Baseline characteristics of all subjects were collected. The 3-minute Delirium diagnostic Scale (3D-CAM) was used to screen the POD group and non-POD group from the recruited subjects during the first 7 days after surgery. Peripheral blood samples were collected 1 day before surgery and 2 day after surgery. . Plasma was isolated from peripheral blood for subsequent proteomic analysis.

Detailed description

Patients undergoing noncardiac surgery were recruited. Baseline characteristics of all subjects were collected. The 3-minute Delirium diagnostic Scale (3D-CAM) was used to screen the POD group and non-POD group from the recruited subjects during the first 7 days after surgery. Peripheral blood samples were collected 1 day before surgery and 2 day after surgery. Plasma was isolated from peripheral blood for subsequent proteomic analysis. To study the characteristics of proteins on a large scale, including protein expression levels, post-translational modifications, protein-protein interactions, etc., so as to obtain a comprehensive understanding of disease occurrence, cell metabolism and other processes at the protein level. Assessment of imbalanced protein expression in peripheral blood using protein profiling may allow us to better understand the pathological changes occurring at the molecular level of POD. Early detection of patients at high risk of POD can optimize perioperative management and promote rapid postoperative recovery.

Conditions

Timeline

Start date
2023-03-20
Primary completion
2025-01-01
Completion
2025-01-01
First posted
2023-03-16
Last updated
2023-03-16

Source: ClinicalTrials.gov record NCT05772026. Inclusion in this directory is not an endorsement.